Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.
Tubiana M, Henry-Amar M, Carde P, Burgers JM, Hayat M, Van der Schueren E, Noordijk EM, Tanguy A, Meerwaldt JH, Thomas J, et al. Tubiana M, et al. Among authors: van der schueren e. Blood. 1989 Jan;73(1):47-56. Blood. 1989. PMID: 2462943 Free article. Clinical Trial.
Late radiation injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: emphasis on the role of exploratory laparotomy and fractionation.
Cosset JM, Henry-Amar M, Burgers JM, Noordijk EM, Van der Werf-Messing B, Meerwaldt JH, van der Schueren E. Cosset JM, et al. Among authors: van der schueren e, van der werf messing b. Radiother Oncol. 1988 Sep;13(1):61-8. doi: 10.1016/0167-8140(88)90299-x. Radiother Oncol. 1988. PMID: 3141982 Clinical Trial.
Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
Carde P, Hayat M, Cosset JM, Somers R, Burgers JM, Sizoo W, Meerwaldt JH, Hagenbeek A, Monconduit M, van der Schueren E, et al. Carde P, et al. Among authors: van der schueren e. NCI Monogr. 1988;(6):303-10. NCI Monogr. 1988. PMID: 3352775 Clinical Trial.
The EORTC treatment of early stages of Hodgkin's disease: the role of radiotherapy.
Tubiana M, Henry-Amar M, Hayat M, Burgers M, Qasim M, Somers R, Sizoo W, van der Schueren E. Tubiana M, et al. Among authors: van der schueren e. Int J Radiat Oncol Biol Phys. 1984 Feb;10(2):197-210. doi: 10.1016/0360-3016(84)90004-x. Int J Radiat Oncol Biol Phys. 1984. PMID: 6368491 Clinical Trial.
Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.
van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Tong D, Winter J, et al. van Dongen JA, et al. Among authors: van der schueren e. Eur J Cancer. 1992;28A(4-5):801-5. doi: 10.1016/0959-8049(92)90118-l. Eur J Cancer. 1992. PMID: 1524898 Clinical Trial.
The Quality Assurance programme of the Radiotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts.
Kouloulias VE, Poortmans PM, Bernier J, Horiot JC, Johansson KA, Davis B, Godson F, Garavaglia G, Pierart M, van der Schueren E. Kouloulias VE, et al. Among authors: van der schueren e. Eur J Cancer. 2003 Mar;39(4):430-7. doi: 10.1016/s0959-8049(02)00113-2. Eur J Cancer. 2003. PMID: 12751372 Review.
205 results